Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Axillary lymph node status together with estrogen and progesterone receptor status are important prognostic factors in breast cancer. In this study, the potential of using MR metabolomics for prediction of these prognostic factors was evaluated. Biopsies from breast cancer patients (n = 160) were excised during surgery and analyzed by high resolution magic angle spinning MR spectroscopy (HR MAS MRS). The spectral data were preprocessed and variable stability (VAST) scaled, and training and test sets were generated using the Kennard-Stone and SPXY sample selection algorithms. The data were analyzed by partial least-squares discriminant analysis (PLS-DA), probabilistic neural networks (PNNs) and Bayesian belief networks (BBNs), and blind samples (n = 50) were predicted for verification. Estrogen and progesterone receptor status was successfully predicted from the MR spectra, and were best predicted by PLS-DA with a correct classification of 44 of 50 and 39 of 50 samples, respectively. Lymph node status was best predicted by BBN with 34 of 50 samples correctly classified, indicating a relationship between metabolic profile and lymph node status. Thus, MR profiles contain prognostic information that may be of benefit in treatment planning, and MR metabolomics may become an important tool for diagnosis of breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLS-regression: a basic tool of chemometrics
Wold, S., Sjöström, M., & Eriksson, L. (2001) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/s0169-7439(01)00155-1 · Cited by 10,084
Cited by
Triple‐negative breast cancer: Present challenges and new perspectives
Podo, F., Buydens, L. M. C., Degani, H., Hilhorst, R., Klipp, E., Gribbestad, I. S., Van Huffel, S., W.M. van Laarhoven, H., Luts, J., Monleon, D., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.006 · Cited by 299
Self-citationNMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
Emwas, A.-H. M., Salek, R. M., Griffin, J. L., & Merzaban, J. (2013) · Metabolomics · doi:10.1007/s11306-013-0524-y · Cited by 296
Early Detection of Recurrent Breast Cancer Using Metabolite Profiling
Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, G. A. N., Owusu-Sarfo, K., Ballas, R. A., & Raftery, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1319 · Cited by 274
Omics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
“On a collection of 50 tumors, Giskeødegård and colleagues demonstrated that highresolution magic angle spinning (HR-MAS)–nuclear magnetic resonance (NMR) spectroscopy may be utilized to assess ER and progesterone receptor status, as well as lymph node status, with classifications from 68% to 88% for these three condit…”
BackgroundHR-MAS NMR Based Quantitative Metabolomics in Breast Cancer
Gogiashvili, M., Nowacki, J., Hergenröder, R., Hengstler, J. G., Lambert, J., & Edlund, K. (2019) · Metabolites · doi:10.3390/metabo9020019 · Cited by 44
“Whereas we here focused primarily on studies that used quantitative HR-MAS NMR to correlate metabolite concentrations with clinicopathological factors, the use of multivariate modelling for prediction of factors, such as tumour grade, oestrogen receptor status and lymph-node status, has also been pursued [46,98].”
Method
Metadata
- Authors
- Giskeødegård, G. F., Grinde, M. T., Sitter, B., Axelson, D. E., Lundgren, S., Fjøsne, H. E., Dahl, S., Gribbestad, I. S., & Bathen, T. F.
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-01-05
- Volume
- 9
- Issue
- 2
- Pages
- 972-979
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2007352226
- Cited by
- 128
- References
- 1
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.